Latin America Boosts sales of Roche

In the first quarter of this year, the company recorded overall sales of 12.4 billion Swiss francs, an increase of 4% over the same period in the previous year. Diagnostic Division, sales rose 5%, totalling 2.6 billion Swiss francs, driven primarily by strong growth in Latin America (21%) and Asia-Pacific (16%). Sales in the pharmaceutical division grew 4%, reaching 9.8 billion Swiss francs.